Ethanethiol, 2-amino-,1-(dihydrogen phosphate), sodium salt (1:1) structure
|
Common Name | Ethanethiol, 2-amino-,1-(dihydrogen phosphate), sodium salt (1:1) | ||
---|---|---|---|---|
CAS Number | 3724-89-8 | Molecular Weight | 179.11000 | |
Density | 1.597g/cm3 | Boiling Point | 384.2ºC at 760mmHg | |
Molecular Formula | C2H7NNaO3PS | Melting Point | 220ºC (dec.)(lit.) | |
MSDS | Chinese USA | Flash Point | 186.2ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of Ethanethiol, 2-amino-,1-(dihydrogen phosphate), sodium salt (1:1)Cysteamine S-phosphate (Cystaphos) sodium can be hydroIyzed to Cysteamine by human alkaline phosphatases. Cysteamine is an orally active agent for the research of nephropathic cystinosis and an antioxidant[1][2]. |
Name | sodium,2-aminoethylsulfanyl(hydroxy)phosphinate |
---|---|
Synonym | More Synonyms |
Description | Cysteamine S-phosphate (Cystaphos) sodium can be hydroIyzed to Cysteamine by human alkaline phosphatases. Cysteamine is an orally active agent for the research of nephropathic cystinosis and an antioxidant[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.597g/cm3 |
---|---|
Boiling Point | 384.2ºC at 760mmHg |
Melting Point | 220ºC (dec.)(lit.) |
Molecular Formula | C2H7NNaO3PS |
Molecular Weight | 179.11000 |
Flash Point | 186.2ºC |
Exact Mass | 178.97800 |
PSA | 121.49000 |
LogP | 0.90950 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn: Harmful; |
Risk Phrases | 22-36/37/38 |
Safety Phrases | S26;S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | TE6483500 |
A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis.
Pediatr. Res. 23(6) , 616-20, (1988) Cysteamine (beta-mercaptoethylamine, MEA) is currently used to treat children with nephropathic cystinosis. In this study MEA was compared to phosphocysteamine (MEAP), a phosphorothioester that tastes... |
|
The treatment of cystinosis with cysteamine and phosphocysteamine in the United Kingdom and Eire.
Pediatr. Nephrol. 9(6) , 685-9, (1995) Fifty-nine patients with cystinosis were treated with cysteamine or phosphocysteamine in the United Kingdom up to May 1990. Treatment was started at a median age of 3.2 years (range 0.6-24.8 years) an... |
|
Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis.
J. Inherit. Metab. Dis. 35(5) , 847-57, (2012) Infantile neuronal ceroid lipofuscinosis (INCL) is a profoundly neurodegenerative disease of children caused by a deficiency in the lysosomal enzyme palmitoyl protein thioesterase-1 (PPT1). There is c... |
Phosphocysteamine |
Tsistafos |
MFCD00038474 |
Cystaphos sodium salt |
Tsistafos (cystafos) |
Cystaphos |
Cistaphos |
S-(2-Aminoethyl) thiophosphate monosodium salt |
EINECS 223-079-5 |
Cystafos |